Castleark Management LLC Atri Cure, Inc. Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$35.1 - $66.01 $1.47 Million - $2.76 Million	-41,745 Reduced 32.2%	87,881 $3.59 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $155,635 - $193,466	-2,710 Reduced 2.05%	129,626 $8.51 Million
Q4 2021 Feb 16, 2022	SELL	$63.4 - $87.14 $864,142 - $1.19 Million	-13,630 Reduced 9.34%	132,336 $9.2 Million
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $2.23 Million - $2.72 Million	32,165 Added 28.26%	145,966 $10.2 Million
Q2 2021 Aug 17, 2021	BUY	$64.13 - $80.18 $7.3 Million - $9.12 Million	113,801 New	113,801 $9.03 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.